Sandu Pharmaceuticals
₹56.79
-0.61 (-1.06%)
23 November, 2024 15:17 BSE: 524703
NSE: SANDUPHQISIN: INE751D01014
Start SIP in Sandu Pharmaceuticals
Start SIPSandu Pharmaceuticals Performance
Day Range
52 Week Range
Sandu Pharmaceuticals Technicals
EMA & SMA
Current Price
₹56.79
-0.61 (-1.06%)
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹57.42
- 50 Day
- ₹58.37
- 100 Day
- ₹59.50
- 200 Day
- ₹60.89
- 20 Day
- ₹56.81
- 50 Day
- ₹59.02
- 100 Day
- ₹59.86
- 200 Day
- ₹61.56
Sandu Pharmaceuticals Resistance and Support
PIVOT
₹56.81
Resistance | |
---|---|
First Resistance | 57.62 |
Second Resistance | 58.45 |
Third Resistance | 59.26 |
RSI | 46.39 |
MFI | 59.11 |
MACD Single Line | -0.40 |
MACD | -0.24 |
Support | |
---|---|
First Support | 55.98 |
Second Support | 55.17 |
Third Supoort | 54.34 |
Sandu Pharmaceuticals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 1,084 | 81,202 | 74.91 |
Week | 1,467 | 111,532 | 76.04 |
1 Month | 5,444 | 405,544 | 74.5 |
6 Month | 10,392 | 772,682 | 74.35 |
Sandu Pharmaceuticals Result Highlights
Sandu Pharmaceuticals Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Sandu Pharmaceuticals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results | |
2024-08-12 | Quarterly Results & Final Dividend | |
2024-06-05 | Audited Results | (Revised) per share(5%)Dividend |
2024-03-30 | Others | Inter alia, to consider : 1. To Consider and Appoint Chief Financial Officer of the Company. per share(5%)Dividend |
2024-02-14 | Quarterly Results |